Page last updated: 2024-10-22

anastrozole and Sjogren's Syndrome

anastrozole has been researched along with Sjogren's Syndrome in 1 studies

Sjogren's Syndrome: Chronic inflammatory and autoimmune disease in which the salivary and lacrimal glands undergo progressive destruction by lymphocytes and plasma cells resulting in decreased production of saliva and tears. The primary form, often called sicca syndrome, involves both KERATOCONJUNCTIVITIS SICCA and XEROSTOMIA. The secondary form includes, in addition, the presence of a connective tissue disease, usually rheumatoid arthritis.

Research Excerpts

ExcerptRelevanceReference
"With these treatments, joint pain is frequent (30% to 40%) and quite often disabling (5% to 10%)."1.34Joint pain with aromatase inhibitors: abnormal frequency of Sjögren's syndrome. ( Borg, S; De Lafontan, B; Laroche, M; Lassoued, S; Roché, H, 2007)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Laroche, M1
Borg, S1
Lassoued, S1
De Lafontan, B1
Roché, H1

Other Studies

1 other study available for anastrozole and Sjogren's Syndrome

ArticleYear
Joint pain with aromatase inhibitors: abnormal frequency of Sjögren's syndrome.
    The Journal of rheumatology, 2007, Volume: 34, Issue:11

    Topics: Aged; Anastrozole; Antibodies, Antinuclear; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; A

2007